Evaluation of procalcitonin immunoassay concordance near clinical decision points
-
Allison B. Chambliss
,
Joshua Hayden
Abstract
Background
Procalcitonin (PCT) is a biomarker for systemic bacterial infections and may aid in decision making for antimicrobial stewardship. Numerous PCT assays are available on common clinical immunoassay platforms. However, questions remain about the harmonization of these assays and whether the same clinical decision points may be used with all methods.
Methods
Thirty-seven remnant patient serum samples were analyzed across four different PCT assays: Abbott ARCHITECT i2000, bioMérieux MINI VIDAS, Roche Elecsys cobas e 411, and BRAHMS KRYPTOR. Regression analysis was performed, and correlation was assessed at common clinical decision points for antimicrobial therapy: 0.10, 0.25, and 0.50 μg/L.
Results
Data showed a positive bias of the MINI VIDAS compared to the KRYPTOR (slope=1.188, R=0.9873) and negative biases of both the ARCHITECT i2000 and cobas e 411 compared to the KRYPTOR (slope=0.806, R=0.8864, and slope=0.795, R=0.8974, respectively). A comparison of results at commonly used clinical decision points for antimicrobial stewardship showed that, relative to the KRYPTOR, 21% of samples would be classified into different interpretive categories by the ARCHITECT i2000 method, 31% of samples would be classified differently by the MINI VIDAS method, and 16% of samples would be classified differently by the cobas e 411 method.
Conclusions
All methods showed reasonable analytical agreement; however, an analysis of result interpretation at clinical decision points showed that many samples were differentially categorized (e.g. shifted by one interpretive category) by the methods. Overall, our findings support a need for harmonization of PCT methods. Until then, institutions should independently evaluate their PCT assays against predicate methods and consider the impact on result interpretation prior to incorporating PCT into clinical practice.
Acknowledgments
The authors wish to acknowledge Holli Mason, MD and Fariba Hashemi, MT(ASCP) at Harbor-UCLA Medical Center for analyzing samples with the BRAHMS KRYPTOR assay, J. Eric Stanford, MHA, MT(ASCP) at Vanderbilt University Medical Center for analyzing samples with the Abbott ARCHITECT i2000 and Roche Elecsys e411 methods, Marybeth M. Romana, MT(ASCP) for analyzing samples at Weill Cornell Medical Center, and Jacob J. Hughey, PhD at Vanderbilt University School of Medicine for assistance with data analysis.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 2010;159:253–64.10.1111/j.1476-5381.2009.00433.xSearch in Google Scholar
2. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206–17.10.1086/421997Search in Google Scholar
3. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463–74.10.1016/S0140-6736(09)61879-1Search in Google Scholar
4. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600–7.10.1016/S0140-6736(04)15591-8Search in Google Scholar
5. Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2017;10:CD007498.10.1002/14651858.CD007498.pub2Search in Google Scholar PubMed PubMed Central
6. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322–31.10.1001/archinternmed.2011.318Search in Google Scholar PubMed
7. U.S. Food & Drug Administration. CLIA – Clinical Laboratory Improvement Amendments: Medical Devices Database. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCLIA/search.cfm. Accessed: 9 October 2018.Search in Google Scholar
8. Jin M, Khan AI. Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med 2010;41:173–7.10.1309/LMQ2GRR4QLFKHCH9Search in Google Scholar
9. Dipalo M, Guido L, Micca G, Pittalis S, Locatelli M, Motta A, et al. Multicenter comparison of automated procalcitonin immunoassays. Pract Lab Med 2015;2:22–8.10.1016/j.plabm.2015.07.001Search in Google Scholar PubMed PubMed Central
10. Ceriotti F, Marino I, Motta A, Carobene A. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor. Clin Chem Lab Med 2017;56:162–9.10.1515/cclm-2017-0159Search in Google Scholar PubMed
11. Schuetz P, Bretscher C, Bernasconi L, Mueller B. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis. Expert Rev Mol Diagn 2017;17:593–601.10.1080/14737159.2017.1324299Search in Google Scholar PubMed
12. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983;21:709–20.10.1515/cclm.1983.21.11.709Search in Google Scholar PubMed
13. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302:1059–66.10.1001/jama.2009.1297Search in Google Scholar PubMed
14. Schuetz P, Christ-Crain M, Huber AR, Müller B. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin Biochem 2010;43:341–4.10.1016/j.clinbiochem.2009.08.029Search in Google Scholar PubMed
15. Wang D, Caddell B, Nolte Frederick S, Babic N. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays. J Appl Lab Med 2019:3.10.1373/jalm.2018.027268Search in Google Scholar PubMed
16. Kutz A, Hausfater P, Oppert M, Alan M, Grolimund E, Gast C, et al. Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods – a prospective multinational trial. Clin Chem Lab Med 2015;54:577–84.10.1515/cclm-2015-0437Search in Google Scholar PubMed
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2018-1362).
©2019 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Sepsis biomarkers: past, present and future
- Reviews
- Making new biomarkers a reality: the case of serum human epididymis protein 4
- Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations
- Opinion Paper
- Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
- EFLM Paper
- Practice in financial support of third party organised conferences and courses at a national level for health care professionals in Europe
- General Clinical Chemistry and Laboratory Medicine
- Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds
- Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
- Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools
- Subcutaneous adipose tissue distribution and telomere length
- Hematology and Coagulation
- Automated measurement of the erythrocyte sedimentation rate: method validation and comparison
- The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants
- Reference Values and Biological Variations
- Narrowed reference intervals for complete blood count in a multiethnic population
- Elucidation of stability profiles of common chemistry analytes in serum stored at six graded temperatures
- Cancer Diagnostics
- Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients
- Cardiovascular Diseases
- Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy
- Infectious Diseases
- Evaluation of procalcitonin immunoassay concordance near clinical decision points
- Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients
- Letters to the Editor
- Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect)
- The short story of the long-term Sigma metric: shift cannot be treated as a linear parameter
- Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI)
- Lesson from inappropriate TSH-receptor antibody measurement in hypothyroidism: case series and literature review
- Instrument dependent erroneous sodium measurements in hypoproteinemic critically ill patients are causing significant misclassification of dysnatremias
- Inherited bisalbuminemia with growth hormone deficiency
- The first report showing de novo partial 21q monosomy in an adult woman with occult primary ovarian insufficiency (POI)
- Reverse-hybridization resolves a rare HFE genotype untypable by real-time PCR and melting curve analysis in a patient with hyperferritinemia and alcoholic liver disease
- Practical problems when incorporating rapidly changing microbial taxonomy into clinical practice
- Congress Abstracts
- SGKC/SSCC Annual Assembly 2019 28th-30th August 2019 Technopark, Zurich or Evidence Based Laboratory Medicine
Articles in the same Issue
- Frontmatter
- Editorial
- Sepsis biomarkers: past, present and future
- Reviews
- Making new biomarkers a reality: the case of serum human epididymis protein 4
- Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations
- Opinion Paper
- Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
- EFLM Paper
- Practice in financial support of third party organised conferences and courses at a national level for health care professionals in Europe
- General Clinical Chemistry and Laboratory Medicine
- Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds
- Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
- Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools
- Subcutaneous adipose tissue distribution and telomere length
- Hematology and Coagulation
- Automated measurement of the erythrocyte sedimentation rate: method validation and comparison
- The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants
- Reference Values and Biological Variations
- Narrowed reference intervals for complete blood count in a multiethnic population
- Elucidation of stability profiles of common chemistry analytes in serum stored at six graded temperatures
- Cancer Diagnostics
- Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients
- Cardiovascular Diseases
- Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy
- Infectious Diseases
- Evaluation of procalcitonin immunoassay concordance near clinical decision points
- Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients
- Letters to the Editor
- Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect)
- The short story of the long-term Sigma metric: shift cannot be treated as a linear parameter
- Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI)
- Lesson from inappropriate TSH-receptor antibody measurement in hypothyroidism: case series and literature review
- Instrument dependent erroneous sodium measurements in hypoproteinemic critically ill patients are causing significant misclassification of dysnatremias
- Inherited bisalbuminemia with growth hormone deficiency
- The first report showing de novo partial 21q monosomy in an adult woman with occult primary ovarian insufficiency (POI)
- Reverse-hybridization resolves a rare HFE genotype untypable by real-time PCR and melting curve analysis in a patient with hyperferritinemia and alcoholic liver disease
- Practical problems when incorporating rapidly changing microbial taxonomy into clinical practice
- Congress Abstracts
- SGKC/SSCC Annual Assembly 2019 28th-30th August 2019 Technopark, Zurich or Evidence Based Laboratory Medicine
